ERAS
Erasca, Inc. · Healthcare · Biotechnology
Input momentum (manajer yang sebanding):
keluasan pemegang -20.0% ·
aliran saham +0.9% ·
posisi baru bersih -20.0%
— formula
Akumulasi terkonsentrasi — peningkatan saham di antara lebih sedikit pemegang
Semua angka kepemilikan: hanya manajer 13F yang dipantau, posisi saham biasa, periode pelaporan Q2 2025
| Kuartal | Pemegang | Δ | Saham | Nilai yang dilaporkan | Baru | Keluar |
|---|---|---|---|---|---|---|
| Q2 2026 | 97 | +13 | 109.93M | $2.01B | +17 | −4 |
| Q1 2026 | 87 | +18 | 99.27M | $1.57B | +25 | −7 |
| Q4 2025 | 69 | +1 | 63.96M | $237.91M | +1 | — |
| Q3 2025 | 16 | +1 | 49.01M | $106.84M | +1 | — |
| Q2 2025 | 12 | -3 | 45.80M | $58.17M | — | −3 |
| Q1 2025 | 12 | 0 | 17.13M | $23.47M | +1 | −1 |
| Q4 2024 | 12 | 0 | 25.73M | $64.58M | +1 | −1 |
| Q3 2024 | 11 | 0 | 18.60M | $50.78M | — | — |
| Q2 2024 | 11 | — | 15.91M | $37.56M | — | — |
| # | Manajer | Saham | Δ saham | Nilai | Bobotnya | Dipegang | ||
|---|---|---|---|---|---|---|---|---|
| 1 | BlackRock ✦ (pasif) | 15.17M | — | $19.26M | 0.0% | n/c | 1 | SEC ↗ |
| 2 | BlackRock ✦ (pasif) | 15.17M | — | $19.26M | 0.0% | n/c | 1 | SEC ↗ |
| 3 | BlackRock ✦ (pasif) | 15.17M | — | $19.26M | 0.0% | n/c | 1 | SEC ↗ |
| 4 | BlackRock ✦ (pasif) | 15.17M | — | $19.26M | 0.0% | n/c | 1 | SEC ↗ |
| 5 | BlackRock ✦ (pasif) | 15.17M | — | $19.26M | 0.0% | n/c | 1 | SEC ↗ |
| 6 | BlackRock ✦ (pasif) | 15.17M | — | $19.26M | 0.0% | n/c | 1 | SEC ↗ |
| 7 | BlackRock ✦ (pasif) | 15.17M | — | $19.26M | 0.0% | n/c | 1 | SEC ↗ |
| 8 | BlackRock ✦ (pasif) | 15.17M | — | $19.26M | 0.0% | n/c | 1 | SEC ↗ |
| 9 | BlackRock ✦ (pasif) | 15.17M | — | $19.26M | 0.0% | n/c | 1 | SEC ↗ |
| 10 | The Vanguard Group ✦ (pasif) | 12.70M | — | $16.12M | 0.0% | n/c | 1 | SEC ↗ |
| 11 | The Vanguard Group ✦ (pasif) | 12.70M | — | $16.12M | 0.0% | n/c | 1 | SEC ↗ |
| 12 | The Vanguard Group ✦ (pasif) | 12.70M | — | $16.12M | 0.0% | n/c | 1 | SEC ↗ |
| 13 | Geode Capital Management ✦ (pasif) | 4.84M | +1.6% | $6.14M | 0.0% | ▲ Add | 5 | SEC ↗ |
| 14 | Geode Capital Management ✦ (pasif) | 4.84M | +1.6% | $6.14M | 0.0% | ▲ Add | 5 | SEC ↗ |
| 15 | State Street Global Advisors ✦ (pasif) | 4.00M | -4.2% | $5.08M | 0.0% | ▼ Trim | 3 | SEC ↗ |
| 16 | Millennium Management ✦ | 3.80M | +17.8% | $4.82M | 0.0% | ▲ Add | 5 | SEC ↗ |
| 17 | Marshall Wace ✦ | 2.07M | +2.3% | $2.63M | 0.0% | ▲ Add | 5 | SEC ↗ |
| 18 | Marshall Wace ✦ | 2.07M | +2.3% | $2.63M | 0.0% | ▲ Add | 5 | SEC ↗ |
| 19 | Wellington Management ✦ | 885.65K | +4.2% | $1.12M | 0.0% | ▲ Add | 3 | SEC ↗ |
| 20 | Wellington Management ✦ | 885.65K | +4.2% | $1.12M | 0.0% | ▲ Add | 3 | SEC ↗ |
| 21 | Wellington Management ✦ | 885.65K | +4.2% | $1.12M | 0.0% | ▲ Add | 3 | SEC ↗ |
| 22 | Renaissance Technologies ✦ | 742.50K | -22.4% | $942,975 | 0.0% | ▼ Trim | 5 | SEC ↗ |
| 23 | AQR Capital Management ✦ | 708.06K | +78.7% | $899,236 | 0.0% | ▲ Add | 5 | SEC ↗ |
| 24 | AQR Capital Management ✦ | 708.06K | +78.7% | $899,236 | 0.0% | ▲ Add | 5 | SEC ↗ |
| 25 | AQR Capital Management ✦ | 708.06K | +78.7% | $899,236 | 0.0% | ▲ Add | 5 | SEC ↗ |
| 26 | AQR Capital Management ✦ | 708.06K | +78.7% | $899,236 | 0.0% | ▲ Add | 5 | SEC ↗ |
| 27 | Two Sigma Investments ✦ | 427.60K | -27.7% | $543,056 | 0.0% | ▼ Trim | 5 | SEC ↗ |
| 28 | Fidelity (FMR) ✦ | 376.98K | — | $478,760 | 0.0% | n/c | 1 | SEC ↗ |
| 29 | Fidelity (FMR) ✦ | 376.98K | — | $478,760 | 0.0% | n/c | 1 | SEC ↗ |
| 30 | T. Rowe Price ✦ | 86.47K | +13.4% | $110,000 | 0.0% | ▲ Add | 5 | SEC ↗ |
"Bobot mereka" = porsi posisi dari total nilai ekuitas 13F yang dilaporkan manajer tersebut — ukuran keyakinan. ✦ = manajer yang dikurasi.
Pembeli baru
| Tidak ada pembeli terlacak baru kuartal ini. |
Telah keluar
| Point72 Asset Management | $55,515 | adalah 0.0% |
| D. E. Shaw & Co. | $43,058 | adalah 0.0% |
| Citadel Advisors | $551 | adalah 0.0% |
Konteks pasar penuh: di SEMUA filer 13F (data terstruktur SEC, Q1 2026): 223 pemegang, 272.55M saham, $4.00B dilaporkan. Ini adalah periode berbeda yang lebih lama dibandingkan angka semesta yang dilacak di atas, dan keduanya tidak pernah dicampur.
Apa lagi yang paling sering dimiliki oleh pemegang efek ini yang dilacak — berdasarkan jumlah kepemilikan bersama, bukan hubungan fundamental.